Publication

Complete hematological and major molecular response through treatment with low-dose Interferon alpha 2a in high-risk polycythemia vera patient: a case report

Journal Paper/Review - Oct 6, 2021

Units
Keywords
PubMed
Doi
Link
Contact

Citation
Driessen C, Noppen C, Boonen G, Drewe J. Complete hematological and major molecular response through treatment with low-dose Interferon alpha 2a in high-risk polycythemia vera patient: a case report. Clin Case Rep 2021; 9:e04903.
Project
Type
Journal Paper/Review (English)
Journal
Clin Case Rep 2021; 9
Publication Date
Oct 6, 2021
Issn Print
2050-0904
Issn Electronic
Pages
e04903
Publisher
Brief description/objective

Low-dose interferon-α 2a treatment may be considered as an alternative to cytoreductive therapy with hydroxyurea or regularly dosed interferon in high-risk polycythemia vera patients.